Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Joyce

Showing results (741-750 of 956) with videos related to

Pageof 96
Sort By:
Cancer Research|July 23, 2013
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cellsDina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, et al.
Frontiers in Pharmacology|August 12, 2021
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure ModelsEvelyne J Demkes, Steven Wenker, Max J M Silvis, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|February 4, 2021
Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette SyndromeKara A Johnson, Gordon Duffley, Thomas Foltynie, et al.
Pilot and Feasibility Studies|March 9, 2023
The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: protocol for a feasibility randomized controlled trialKayla M Joyce, Charlie Rioux, Anna L MacKinnon, et al.
Schizophrenia Bulletin|March 4, 2023
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode ParticipantsTil Wykes, Dominic Stringer, Janette Boadu, et al.
The New England Journal of Medicine|December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host diseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Blood Advances|April 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemiaBenjamin L Lampson, Haesook T Kim, Matthew S Davids, et al.
Schizophrenia (Heidelberg, Germany)|September 30, 2023
Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scaleJoanne Evans, Rose Tinch-Taylor, Emese Csipke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma CommitteeB L Eisenburg, K Alektiar, M Ballo, et al.
Hemasphere|April 3, 2024
Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphomaReid W Merryman, Justin Rhoades, Kan Xiong, et al.
Pageof 96

Showing results (741-750 of 956) with videos related to

Sort By:
Pageof 96
Cancer Research|July 23, 2013
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cellsDina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, et al.
Frontiers in Pharmacology|August 12, 2021
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure ModelsEvelyne J Demkes, Steven Wenker, Max J M Silvis, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|February 4, 2021
Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette SyndromeKara A Johnson, Gordon Duffley, Thomas Foltynie, et al.
Pilot and Feasibility Studies|March 9, 2023
The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: protocol for a feasibility randomized controlled trialKayla M Joyce, Charlie Rioux, Anna L MacKinnon, et al.
Schizophrenia Bulletin|March 4, 2023
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode ParticipantsTil Wykes, Dominic Stringer, Janette Boadu, et al.
The New England Journal of Medicine|December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host diseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Blood Advances|April 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemiaBenjamin L Lampson, Haesook T Kim, Matthew S Davids, et al.
Schizophrenia (Heidelberg, Germany)|September 30, 2023
Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scaleJoanne Evans, Rose Tinch-Taylor, Emese Csipke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma CommitteeB L Eisenburg, K Alektiar, M Ballo, et al.
Hemasphere|April 3, 2024
Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphomaReid W Merryman, Justin Rhoades, Kan Xiong, et al.
Pageof 96